Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Moxibustion for Cold-Syndrome Allergic Rhinitis
NCT07537439Active, not recruiting
- Sponsor
- University of Medicine and Pharmacy of Ho Chi Minh City
- Start
- Mar 2026
- Primary completion
- Aug 2026
- Countries
- 1
01
Overview
Randomised trial in allergic rhinitis (AR) (2 arms), sponsored by University of Medicine and Pharmacy of Ho Chi Minh City. Primary endpoint: Total Nasal Symptom Score at 4 weeks. Started Mar 2026; status: active, not recruiting.
02
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on NCT07537439.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07537439.